PVP Ventures Ltd
Incorporated in 1991, PVP Ventures
Ltd develops urban infrastructure
and investments in various ventures[1]
- Market Cap ₹ 668 Cr.
- Current Price ₹ 25.7
- High / Low ₹ 39.3 / 20.1
- Stock P/E 295
- Book Value ₹ 8.64
- Dividend Yield 0.00 %
- ROCE -2.20 %
- ROE -3.45 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -25.5% over past five years.
- Debtor days have increased from 31.4 to 77.1 days.
- Company's cost of borrowing seems high
- Working capital days have increased from 724 days to 1,248 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Realty Industry: Construction
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
47.77 | 63.47 | 53.36 | 143.77 | 155.60 | 58.43 | 36.81 | 43.72 | 17.84 | 48.76 | 175.68 | 8.47 | 11.85 | |
12.78 | 30.97 | 64.53 | 140.32 | 110.98 | 67.40 | 80.94 | 64.42 | 31.38 | 41.51 | 46.28 | 20.41 | 27.82 | |
Operating Profit | 34.99 | 32.50 | -11.17 | 3.45 | 44.62 | -8.97 | -44.13 | -20.70 | -13.54 | 7.25 | 129.40 | -11.94 | -15.97 |
OPM % | 73.25% | 51.21% | -20.93% | 2.40% | 28.68% | -15.35% | -119.89% | -47.35% | -75.90% | 14.87% | 73.66% | -140.97% | -134.77% |
10.38 | -3.77 | 2.96 | 53.44 | 2.09 | 0.45 | -11.20 | 1.66 | -3.80 | -33.45 | 216.10 | 80.23 | 15.90 | |
Interest | 0.45 | 20.31 | 21.84 | 51.18 | 47.18 | 50.88 | 59.25 | 69.15 | 61.32 | 68.16 | 10.09 | 5.39 | 3.95 |
Depreciation | 0.15 | 0.21 | 0.60 | 1.16 | 1.11 | 1.09 | 1.71 | 2.46 | 1.96 | 0.87 | 1.12 | 1.90 | 2.55 |
Profit before tax | 44.77 | 8.21 | -30.65 | 4.55 | -1.58 | -60.49 | -116.29 | -90.65 | -80.62 | -95.23 | 334.29 | 61.00 | -6.57 |
Tax % | 20.35% | 65.90% | 8.58% | 92.75% | -620.25% | 2.61% | 0.03% | 2.98% | 0.00% | 0.00% | 7.42% | -8.13% | |
35.67 | 2.81 | -33.29 | 0.33 | 8.22 | -62.06 | -116.32 | -93.36 | -80.62 | -95.22 | 309.51 | 65.96 | 1.42 | |
EPS in Rs | 1.46 | 0.11 | -1.04 | 0.01 | 0.34 | -2.53 | -4.75 | -2.48 | -2.30 | -2.43 | 8.79 | 2.55 | 0.08 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | -18% |
5 Years: | -25% |
3 Years: | -22% |
TTM: | 80% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 14% |
3 Years: | 23% |
TTM: | 106% |
Stock Price CAGR | |
---|---|
10 Years: | 17% |
5 Years: | % |
3 Years: | 62% |
1 Year: | -23% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | -3% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 243.96 | 243.96 | 243.96 | 243.96 | 243.96 | 243.96 | 243.96 | 243.96 | 243.96 | 243.96 | 243.96 | 260.40 | 260.40 |
Reserves | 193.81 | 183.19 | 142.60 | -9.28 | 4.61 | -31.89 | -114.17 | -176.39 | -232.72 | -289.65 | -95.89 | -30.87 | -35.38 |
141.60 | 164.62 | 142.74 | 362.91 | 302.40 | 348.87 | 369.93 | 358.67 | 355.27 | 372.93 | 119.20 | 43.23 | 15.62 | |
216.77 | 186.47 | 151.90 | 223.12 | 224.80 | 167.26 | 169.67 | 184.87 | 199.32 | 178.11 | 71.41 | 106.44 | 138.65 | |
Total Liabilities | 796.14 | 778.24 | 681.20 | 820.71 | 775.77 | 728.20 | 669.39 | 611.11 | 565.83 | 505.35 | 338.68 | 379.20 | 379.29 |
98.93 | 85.18 | 69.48 | 3.80 | 4.20 | 13.36 | 12.39 | 13.78 | 4.81 | 3.93 | 3.88 | 43.43 | 44.14 | |
CWIP | 0.00 | 0.00 | 0.10 | 2.76 | 8.66 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 167.36 | 147.63 | 150.19 | 51.81 | 51.85 | 43.88 | 32.99 | 29.04 | 17.57 | 14.21 | 9.48 | 7.74 | 3.11 |
529.85 | 545.43 | 461.43 | 762.34 | 711.06 | 670.96 | 624.01 | 568.29 | 543.45 | 487.21 | 325.32 | 328.03 | 332.04 | |
Total Assets | 796.14 | 778.24 | 681.20 | 820.71 | 775.77 | 728.20 | 669.39 | 611.11 | 565.83 | 505.35 | 338.68 | 379.20 | 379.29 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-9.67 | -20.65 | 65.68 | 28.11 | 48.35 | -8.20 | -12.97 | 17.43 | 6.21 | -13.08 | 327.32 | 0.04 | |
31.54 | 17.88 | -23.09 | 12.30 | 18.92 | 7.23 | 19.51 | 1.99 | 7.32 | -7.85 | -123.40 | 6.87 | |
-21.32 | 2.75 | -43.66 | -40.16 | -62.56 | -3.63 | -6.04 | -20.88 | -9.94 | 17.33 | -202.55 | -7.85 | |
Net Cash Flow | 0.55 | -0.02 | -1.07 | 0.26 | 4.71 | -4.59 | 0.50 | -1.46 | 3.59 | -3.60 | 1.36 | -0.94 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 13.60 | 14.38 | 20.66 | 14.32 | 53.08 | 79.21 | 16.16 | 12.52 | 33.14 | 12.73 | 4.22 | 77.14 |
Inventory Days | 0.00 | 0.00 | 0.00 | 40,980.34 | 9,891.18 | |||||||
Days Payable | 270.93 | 52.00 | ||||||||||
Cash Conversion Cycle | 13.60 | 14.38 | 20.66 | 14.32 | 53.08 | 79.21 | 16.16 | 12.52 | 33.14 | 40,722.14 | 9,843.39 | 77.14 |
Working Capital Days | -853.63 | -463.11 | -413.63 | 1,295.28 | 980.50 | 2,259.53 | 2,688.86 | 1,154.02 | 2,967.88 | 373.01 | 550.35 | 1,247.55 |
ROCE % | 8.08% | 7.74% | 0.29% | 6.13% | 7.28% | -1.65% | -8.79% | -5.48% | -4.36% | 3.08% | 61.18% | -2.20% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
1d - PVP acquires 52% stake in Biohygea, expanding into healthcare diagnostics in Tier 2/3 cities.
-
Announcement under Regulation 30 (LODR)-Updates on Acquisition
1d - PVP Ventures acquires 52% stake in Biohygea Global for Rs. 7 crore, making it a subsidiary.
-
Press Release
2d - PVP acquires 56% of Optimus Oncology for INR 55 Cr, plans 76% stake, expanding oncology services in Tier 2/3 cities.
-
Appointment of Company Secretary and Compliance Officer
2d - PVP Ventures to acquire 56% of Optimus Oncology for INR 55 crore; new Company Secretary appointed.
-
Announcement under Regulation 30 (LODR)-Acquisition
2d - PVP Ventures to acquire 56% of Optimus Oncology for INR 55 crore, expanding healthcare footprint.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from nse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
PVPVL is the holding company of the Hyderabad based PVP group, which has business interests in real estate, media & entertainment. The Group is engaged in developing urban infrastructure including residential projects, movie production and movie financing related activities.